miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas Lei ShiDongyi JiangZhimin Wang Laboratory Investigation 14 August 2012 Pages: 155 - 162
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233 Steven N. GurleyAmmaar H. AbidiBob M. Moore II Laboratory Investigation 09 August 2012 Pages: 163 - 177
CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma You-ke XieShao-fen HuoChuan Jin Laboratory Investigation 24 August 2012 Pages: 179 - 186
The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27 Junyang LiWeixing HuQing Lan Laboratory Investigation 18 August 2012 Pages: 187 - 194
Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis Jinxu ZhouTao XuJuxiang Chen Laboratory Investigation 13 September 2012 Pages: 195 - 203
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system Dominique Figarella-BrangerCorinne BouvierPhilippe Metellus Clinical Study 14 August 2012 Pages: 205 - 213
Increased risk of cancer after Bell’s palsy: a 5-year follow-up study Jau-Jiuan SheuJoseph J. KellerHerng-Ching Lin Clinical Study 14 August 2012 Pages: 215 - 220
Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature Alexander TinchonStefan OberndorferWolfgang Grisold Clinical Study 14 August 2012 Pages: 221 - 226
Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma Shota TanakaFredric B. MeyerIan F. Parney Clinical Study 09 August 2012 Pages: 227 - 235
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas Sean A. GrimmMaryanne MarymontJeffrey J. Raizer Clinical Study 09 August 2012 Pages: 237 - 243
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas Phioanh Leia NghiemphuAlbert LaiTimothy Cloughesy Clinical Study Open access 24 August 2012 Pages: 245 - 250
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease Anna Maria DeliosMarc RosenblumLisa M. DeAngelis Clinical Study 23 August 2012 Pages: 251 - 256
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme Kenneth F. GrossmannHoward ColmanRandy L. Jensen Clinical Study 30 August 2012 Pages: 257 - 264
Chemosensitized radiosurgery for recurrent brain metastases David RobergeLuis SouhamiJean-François Pouliot Clinical Study 22 August 2012 Pages: 265 - 270
Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma Todd C. HankinsonEmma C. FieldsArthur K. Liu Clinical Study 23 August 2012 Pages: 271 - 278
Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas Matthias HoldhoffXiaobu YeLuis A. Diaz Jr. Clinical Study 29 August 2012 Pages: 279 - 285
Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors Cynthia J. CampenJoanna DearlovePaul Graham Fisher Clinical Study 02 September 2012 Pages: 287 - 291
Validation of the Mishel’s uncertainty in illness scale-brain tumor form (MUIS-BT) Lin LinAlvina A. AcquayeTerri S. Armstrong Clinical Study 11 September 2012 Pages: 293 - 300
Declarative memory disorders in patients with brain tumors can improve after cognitive training intervention: evidence from functional MRI Eliane C. Miotto Letter to the Editor 14 August 2012 Pages: 301 - 302
Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system Benjamin BrokinkelSusanne Peetz-DienhartMartin Hasselblatt Letter to the Editor 23 August 2012 Pages: 303 - 304
